Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|November 24, 2025
Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancerBobak Parang, Liron Yoffe, Rabia Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2023
Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406)Lee D Cranmer, Yao Lu, Rachel S Heise, et al.
JACC. Cardiovascular Interventions|April 24, 2025
Association Between Myocardial Infarction and Quality of Life in the ISCHEMIA TrialMario Gaudino, Gregg W Stone, Rachel S Heise, et al.
JAMA Oncology|May 31, 2026
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM StudyYiwey Shieh, Rachel S Heise, Lisa Madlensky, et al.
NPJ Precision Oncology|May 15, 2023
Development and testing of a polygenic risk score for breast cancer aggressivenessYiwey Shieh, Jacquelyn Roger, Christina Yau, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
Genome Medicine|August 28, 2025
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trialKirkpatrick B Fergus, Rachel S Heise, Lisa Madlensky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.
Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.
Pageof 1